Coronavirus Update: Moderna In Advanced Talks With Europe On Vaccine Supplies
Plus: Panacea Exits Joint Venture
The deal would include an option for expansion to 160 million doses of the mRNA-based vaccine.
The deal would include an option for expansion to 160 million doses of the mRNA-based vaccine.